JP2002531527A5 - - Google Patents

Download PDF

Info

Publication number
JP2002531527A5
JP2002531527A5 JP2000586368A JP2000586368A JP2002531527A5 JP 2002531527 A5 JP2002531527 A5 JP 2002531527A5 JP 2000586368 A JP2000586368 A JP 2000586368A JP 2000586368 A JP2000586368 A JP 2000586368A JP 2002531527 A5 JP2002531527 A5 JP 2002531527A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000586368A
Other languages
Japanese (ja)
Other versions
JP3805625B2 (ja
JP2002531527A (ja
Filing date
Publication date
Priority claimed from GBGB9826882.4A external-priority patent/GB9826882D0/en
Application filed filed Critical
Publication of JP2002531527A publication Critical patent/JP2002531527A/ja
Publication of JP2002531527A5 publication Critical patent/JP2002531527A5/ja
Application granted granted Critical
Publication of JP3805625B2 publication Critical patent/JP3805625B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000586368A 1998-12-07 1999-12-06 マクロライドの安定化 Expired - Lifetime JP3805625B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9826882.4 1998-12-07
GBGB9826882.4A GB9826882D0 (en) 1998-12-07 1998-12-07 Organic compounds
GBGB9904934.8A GB9904934D0 (en) 1998-12-07 1999-03-04 Organic compounds
GB9904934.8 1999-03-04
PCT/EP1999/009521 WO2000033878A2 (en) 1998-12-07 1999-12-06 Stabilization of macrolides

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2005106512A Division JP5043308B2 (ja) 1998-12-07 2005-04-01 マクロライドの安定化
JP2005378514A Division JP5165199B2 (ja) 1998-12-07 2005-12-28 マクロライドの安定化

Publications (3)

Publication Number Publication Date
JP2002531527A JP2002531527A (ja) 2002-09-24
JP2002531527A5 true JP2002531527A5 (https=) 2005-12-22
JP3805625B2 JP3805625B2 (ja) 2006-08-02

Family

ID=26314797

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000586368A Expired - Lifetime JP3805625B2 (ja) 1998-12-07 1999-12-06 マクロライドの安定化
JP2005106512A Expired - Lifetime JP5043308B2 (ja) 1998-12-07 2005-04-01 マクロライドの安定化
JP2005378514A Expired - Lifetime JP5165199B2 (ja) 1998-12-07 2005-12-28 マクロライドの安定化

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2005106512A Expired - Lifetime JP5043308B2 (ja) 1998-12-07 2005-04-01 マクロライドの安定化
JP2005378514A Expired - Lifetime JP5165199B2 (ja) 1998-12-07 2005-12-28 マクロライドの安定化

Country Status (38)

Country Link
US (5) US6605613B2 (https=)
EP (4) EP2269651A3 (https=)
JP (3) JP3805625B2 (https=)
KR (2) KR100695834B1 (https=)
CN (2) CN1876657B (https=)
AR (3) AR026102A1 (https=)
AT (1) ATE365051T1 (https=)
AU (1) AU759219B2 (https=)
BE (1) BE1012869A3 (https=)
BR (1) BR9915986A (https=)
CA (3) CA2351580C (https=)
CO (1) CO4980847A1 (https=)
CY (1) CY1106870T1 (https=)
CZ (2) CZ302210B6 (https=)
DE (1) DE69936352T3 (https=)
DK (1) DK1137439T4 (https=)
ES (1) ES2288033T5 (https=)
FR (1) FR2786771B1 (https=)
GB (2) GB9826882D0 (https=)
HK (1) HK1038889B (https=)
HU (2) HU230174B1 (https=)
ID (1) ID29250A (https=)
IL (1) IL143092A0 (https=)
IT (1) IT1319701B1 (https=)
MY (2) MY127579A (https=)
NO (2) NO332698B1 (https=)
NZ (2) NZ511936A (https=)
PE (1) PE20001333A1 (https=)
PL (2) PL196627B1 (https=)
PT (1) PT1137439E (https=)
RU (1) RU2243769C2 (https=)
SG (1) SG151072A1 (https=)
SI (1) SI1137439T2 (https=)
SK (2) SK286688B6 (https=)
TR (2) TR200101416T2 (https=)
TW (2) TWI248938B (https=)
WO (1) WO2000033878A2 (https=)
ZA (1) ZA200104360B (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
MXPA04007847A (es) 2002-02-13 2005-02-24 Biogal Gyogyszergyar Metodo para extraer un macrolido de biomateria.
US7452692B2 (en) 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
AR040693A1 (es) * 2002-07-30 2005-04-13 Wyeth Corp Formulaciones parenterales
WO2004089958A2 (en) * 2003-03-31 2004-10-21 TEVA Gyógyszergyár Részvénytársaság Crystallization and purification of macrolides
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
PL1558622T3 (pl) 2003-07-24 2008-06-30 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Sposób oczyszczania makrolidów
KR20060085246A (ko) 2003-09-18 2006-07-26 마커사이트, 인코포레이티드 경공막 전달
US9114198B2 (en) * 2003-11-19 2015-08-25 Advanced Cardiovascular Systems, Inc. Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
KR20060126701A (ko) * 2003-12-10 2006-12-08 애크럭스 디디에스 피티와이 리미티드 경피 또는 국소 약물 전달에 따른 원치않는 효과의치료방법
US8551512B2 (en) * 2004-03-22 2013-10-08 Advanced Cardiovascular Systems, Inc. Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS
MX2007003731A (es) * 2004-09-29 2007-08-14 Johnson & Johnson Formas de dosis farmaceuticas de compuestos similares a rapamicina amorfos estables.
DK1848431T3 (en) 2005-02-09 2016-04-18 Santen Pharmaceutical Co Ltd LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
WO2007067566A2 (en) * 2005-12-07 2007-06-14 Wyeth Methods for preparing crystalline rapamycin and for measuring crystallinity of rapamycin compounds using differential scanning calorimetry
US7700614B2 (en) * 2005-12-14 2010-04-20 Abbott Laboratories One pot synthesis of tetrazole derivatives of rapamycin
US20070142422A1 (en) * 2005-12-20 2007-06-21 Wyeth Control of CCI-779 dosage form stability through control of drug substance impurities
KR20140093764A (ko) * 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
ES2563288T3 (es) 2006-03-23 2016-03-14 Santen Pharmaceutical Co., Ltd Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
JP2013527223A (ja) 2010-06-02 2013-06-27 フレゼニウス・カビ・オンコロジー・リミテッド ラパマイシンエステルの安定な医薬組成物
CN103025753A (zh) * 2010-06-07 2013-04-03 泰立克公司 晶体盐酸依泽替米贝非溶剂化物
WO2012017449A1 (en) * 2010-08-04 2012-02-09 Meril Life Sciences Pvt. Ltd Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties"
ES2753529T3 (es) 2010-11-19 2020-04-13 Biocon Ltd Procesos para la preparación de everolimús y productos intermedios del mismo
JP2014516075A (ja) 2011-06-06 2014-07-07 シェブロン フィリップス ケミカル カンパニー エルピー 癌治療のためのメタロセン化合物の使用
WO2013022201A1 (en) * 2011-08-11 2013-02-14 Dong-A Pharm. Co., Ltd. Process of preparing a stabilized and solubilized formulation of sirolimus derivatives
US9610385B2 (en) 2013-03-07 2017-04-04 Abbott Cardiovascular Systems Inc. Method of fabricating an implantable medical device comprising a rapamycin derivative
IN2013MU02532A (https=) 2013-07-31 2015-06-26 Sahajanand Medical Technologies Pvt Ltd
CN104721158B (zh) * 2013-12-24 2018-01-30 正大天晴药业集团股份有限公司 一种稳定的依维莫司片剂
CN104892632B (zh) * 2015-06-03 2017-12-26 道中道(菏泽)制药有限公司 一种晶体形式的依维莫司及其制备方法
EP3329916A4 (en) 2015-07-28 2019-03-20 Nippon Kayaku Kabushiki Kaisha PHARMACEUTICAL COMPOSITION COMPRISING RAPAMYCIN OR A DERIVATIVE THEREOF, AND PROCESS FOR PRODUCING THE SAME
JP6793651B2 (ja) * 2015-08-28 2020-12-02 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物
US20190038605A1 (en) * 2015-09-18 2019-02-07 Nippon Kayaku Kabushiki Kaisha Pharmaceutical composition comprising rapamycin or derivative thereof
WO2017129772A1 (en) 2016-01-29 2017-08-03 Xellia Phamaceuticals Aps Stable pharmaceutical compositions of temsirolimus
WO2017204215A1 (ja) 2016-05-27 2017-11-30 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物
KR102051806B1 (ko) * 2018-01-12 2019-12-04 주식회사 종근당 에베로리무스를 포함하는 안정화된 약제학적 제제
EP4126882A1 (en) * 2020-03-27 2023-02-08 Boston Scientific Scimed Inc. Methods for crystallization of drugs
JP2023028473A (ja) * 2021-08-19 2023-03-03 日本マイクロバイオファーマ株式会社 エベロリムスの製造方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US3996355A (en) 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4049128A (en) 1976-11-18 1977-09-20 Westinghouse Air Brake Company Control system for automatic railway car coupler
AU543727B2 (en) * 1980-06-02 1985-05-02 Ayerst Mckenna & Harrison Inc. Injectable composition of rapamycin
GB8803836D0 (en) 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
JPH01249651A (ja) 1988-02-18 1989-10-04 E I Du Pont De Nemours & Co セラミツク/蒸留可能な結合剤組成物
KR0159766B1 (ko) * 1989-10-16 1998-12-01 후지사와 토모키치로 양모제 조성물
JPH04230389A (ja) * 1990-07-16 1992-08-19 American Home Prod Corp ラパマイシン誘導体
FI97472C (fi) * 1991-05-07 1996-12-27 American Home Prod Menetelmä terapeuttisesti käyttökelpoisten rapamysiinijohdannaisten valmistamiseksi anti-inflammatorisina ja antifungaalisina aineina
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
SG47580A1 (en) 1992-10-13 1998-04-17 American Home Prod Carbamates of rapamycin
US5302584A (en) * 1992-10-13 1994-04-12 American Home Products Corporation Carbamates of rapamycin
RU2181054C2 (ru) * 1994-11-02 2002-04-10 Новартис Аг Микроэмульсионный предконцентрат
US5985890A (en) 1995-06-09 1999-11-16 Novartis Ag Rapamycin derivatives
FR2736550B1 (fr) * 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
PT956034E (pt) * 1996-07-30 2002-12-31 Novartis Ag Composicoes farmaceuticas para o tratamento da rejeicao de transplantes estados inflamatorios ou auto-imunes compreendendo ciclosporina a e 40-o-(2-hidroxietil)-rapamicina
US6362264B1 (en) * 1996-12-20 2002-03-26 Ck Witco Corporation Stabilizer for food contact and medical grade PVC
CA2279259A1 (en) 1997-02-04 1998-08-06 Abbott Laboratories Pain reducing parenteral liposome formulation

Similar Documents

Publication Publication Date Title
BE2018C020I2 (https=)
BE2015C057I2 (https=)
BE2016C007I2 (https=)
BE2015C018I2 (https=)
BE2014C017I2 (https=)
BE2013C051I2 (https=)
BE2013C020I2 (https=)
BE2013C015I2 (https=)
BE2013C001I2 (https=)
BRPI0017527B8 (https=)
IN2001KO01233A (https=)
JP2002524356A5 (https=)
JP2002508994A5 (https=)
JP2002531720A5 (https=)
BRPI0001672A2 (https=)
JP2002504431A5 (https=)
JP2002522685A5 (https=)
JP2002512891A5 (https=)
JP2002518463A5 (https=)
BRPI0001542A2 (https=)
JP2002531527A5 (https=)
BRPI0012675B8 (https=)
BRPI0017522A2 (https=)
JP2002519677A5 (https=)
IN191492B (https=)